Cerba Research’s Post

Vaccine development requires clinical trials to generate the necessary safety, quality and efficacy data needed for licensure. The process takes on average 10–15 years and costs at least $500M, with probability of success estimated to be as low as 10%.

International clinical trials are essential to evaluating the safety and efficacy of new treatments, but their success can be hampered by a variety of challenges. From navigating data sharing challenges to overcoming global disruptions, today's sponsored blog from H1 explores the complexities of ensuring equitable vaccine distribution and successful trial outcomes. Read more > https://bit.ly/4cer1ca #SponsoredContent #H1 #ClinicalResearch #ClinicalTrials #InternationalClinicalTrials #DataSharing #GlobalDisruptions #VaccineDistribution

Vaccine Manufacturing -- the Difference between a science project and Product to Patients!! This is an excellent illustration of the paths and challenges of vaccine manufacturing which are critical to successfully delivering life-enhancing and many times, life-saving, vaccines to appropriate patient populations. GeoVax currently has an advanced MVA manufacturing process in transition, utilizing avian cell line, departing from the legacy, cumbersome CEF process. The anticipated result will be (1) faster manufacturing in support of addressing epidemics and pandemics, (2) higher yield and (3) lower cost. This represents our challenge and commitment to improving lives worldwide through transformative, affordable innovation.

Ever wondered how vaccines are made? The process is intricate, lengthy, and capital-intensive, demanding cutting-edge science, advanced technologies, and highly skilled personnel. This new infographic created in collaboration with IFPMA, delves deep into the vaccine manufacturing chain, highlighting each stage and the critical stakeholders involved in testing. Vaccine manufacturing is not just about following a recipe, it is about constantly innovating and improving. Leveraging the latest scientific advancements ensures that vaccines are safe, effective, and available to those who need them. The journey from lab to jab is complex, but it is this very complexity that ensures the vaccines we rely on are safe and effective. Behind every vaccine is a team of dedicated professionals working tirelessly to protect public health. #VaccineConfidence #PublicHealth #VaccineDevelopment #InnovationInHealth #GlobalHealth #DCVMN

Today's tip of the day: always think of your transferrable skills. You never know where they will lead you! #networking #transferrableskills #connecttocollaborateinscience #crosscollaboration #research #researchparticipant #clinicaltrials #RSV #vaccineresearch #clinicalstudy

Discover the new vaccines on the horizon and what you need to know to stay protected. From advancements in technology to potential benefits, our latest article covers it all. 🔗 Don't miss out on this crucial information, read here: https://lnkd.in/dM26y9zs

💉 Computer modeling techniques that accelerated the production of COVID-19 vaccines could benefit the wider vaccine sector if international regulators develop harmonized guidelines. Traditional methods of vaccine development take a long time and have limitations. Model-based approaches have the potential to significantly reduce the cost and time required for vaccine process development. However, regulatory acceptance and guidelines are necessary for their implementation. #BioprocessUpdates #VaccineSector #ProcessModeling #ComputerModeling #COVID19Vaccines #VaccineProduction #HarmonizedGuidelines #TraditionalMethods #ModelBasedApproaches #RegulatoryAcceptance #VaccineProcessDevelopment #CostReduction #TimeEfficiency #InternationalRegulators #VaccineInnovation #HealthcareTechnology ▷ Read the full article here: 📎 https://lnkd.in/dZtRj7w8

In last week's lecture for BUS 120, we discussed the overarching need for corporations like Big Pharma to be the ones to help manufacture, sponsor and aid global health crises. About the class and the opportunity for extra credit, I was able to listen to a Ted Talk that emphasized the global corporation that helped alleviate the effects of COVID-19. Kiran Mazumdar-Shaw conducted the seminar titled, "The global cooperation that accelerated the COVID-19 Vaccines." It dives into the general need and wants for aid in lower-income countries that will help benefit larger countries with more innovation. Check it out! https://lnkd.in/ezSH5u3t Erin Whitehurst BUS 120

💡Did you know that an ALiCE® cell-free reaction can produce any vaccine-relevant protein in just 24-48 hours? Join us at the World Vaccine Congress Europe to see how our cell-free technology is making rapid, scalable vaccine production a reality. Swing by Booth #111 and learn how we’re helping vaccine developers speed up their path to clinic. 👇Here’s what we have lined up for the event. #WorldVaccineCongress #VaccineDevelopment #CellFreeTechnology